MODIFIERS OF MYOCARDIAL INFARCTION ONSET
MODIFIERS OF MYOCARDIAL INFARCTION ONSET
批准号:
2028400
负责人:
JAMES E MULLER
金额:
$49.22万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-04-01 至 1998-11-30
关键词:
acute disease /disorder aspirin beta antiadrenergic agent cardiovascular disorder epidemiology cardiovascular disorder prevention case history chemoprevention circadian rhythms data collection methodology /evaluation diet disease /disorder proneness /risk exercise gender difference human subject interview myocardial infarction physiologic stressor psychological stressor questionnaires smoking stress
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This is a revised competing renewal application to conduct a study
entitled Modifiers of Myocardial Infarction Onset (Modifiers Study) to
elucidate the pathophysiology of acute myocardial infarction (Ml)
onset. We will utilize the methodologic techniques, 50-hospital
national study group, and findings of the completed NHLBl-funded
Determinants of Myocardial Infarction Onset Study (Determinants Study).
The Modifiers Study will identify factors that increase or decrease the
susceptibility of patients to the triggers of acute Ml we have
previously identified.
The Determinants Study began in 1989, shortly after widespread
acceptance of the circadian variation in Ml occurrence. The study was
initiated to utilize state-of-the art epidemiologic techniques to
determine the role of daily activities in the triggering of Ml. The
investigators created a new epidemiologic technique (the case-crossover
method), developed and tested a 24-page interview form established a
large study group of hospitals with trained interviewers, instituted
quality control measures, and enrolled over 2,000 subjects. This
extensive activity has made the Determinants Study a centerpiece in the
developing field of research into triggering of acute disease onset.
The Determinants Study accomplished its four Specific Aims. It
demonstrated that awakening/activity, rather than the absolute time of
day, is responsible for morning triggering, that heavy exertion, anger,
and sexual activity are triggers of Ml with relative risks of 6, 3, and
2 respectively, that beta-blockade prevents triggering by
awakening/activity, and that a sedentary lifestyle markedly increases
the relative risk of triggering of Ml by heavy exertion.
The proposed Modifiers Study will answer the major questions raised by
the results of the Determinants Study. It will test hypotheses
concerning 5 groups of factors that are potential modifiers of
susceptibility to the triggering of acute MI: l) Pharmacologic means
of Prevention - that beta blockers, aspirin, angiotensin converting
enzyme inhibitors and estrogen use decrease susceptibility to triggers;
2) Timing - that susceptibility does not increase in the morning but
does in the winter, and that exogenous rather than endogenous daily
rhythms determine onset; 3) Traditional chronic risk factors - that
diabetes, hypertension, and smoking increase susceptibility and that
regular exercise decreases susceptibility (to triggers other than
exertion); 4) Gender - that women are less susceptible to triggering;
and 5) Dietary factors - that chronic moderate alcohol use and anti-
oxidants decrease susceptibility.
To test the above hypotheses, 5,700 interviews are needed. By the
completion of the Determinants Study in March 1993, over 2,000
interviews will be complete. Continuation in the Modifiers Study of
our current 77 interviews per month will provide the required 3,700
additional interviews by December 1997. To maintain the study
organization during the 8 month review of the Modifiers Study, we will
support nurse interviewing with limited non-federal funds.
The long-term goal of the proposed study is to identify more completely
the mechanisms by which triggering occurs, and thereby facilitate
identification of new means of prevention. Although most potential
triggering activities are unavoidable, triggering of acute Ml could be
prevented by using drugs or other interventions to sever the
physiologic link between potential triggers and their catastrophic
consequences.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DETERMINANTS OF THE ONSET OF MYOCARDIAL INFARCTION
-
批准号:3358467
-
项目类别:
-
资助金额:$46.48万
-
财政年份:1990
-
负责人:JAMES E MULLER
-
依托单位:
DETERMINANTS OF THE ONSET OF MYOCARDIAL INFARCTION
-
批准号:3358468
-
项目类别:
-
资助金额:$39.66万
-
财政年份:1990
-
负责人:JAMES E MULLER
-
依托单位:
MODIFIERS OF MYOCARDIAL INFARCTION ONSET
-
批准号:2219857
-
项目类别:
-
资助金额:$45.11万
-
财政年份:1990
-
负责人:JAMES E MULLER
-
依托单位:
MODIFIERS OF MYOCARDIAL INFARCTION ONSET
-
批准号:2219856
-
项目类别:
-
资助金额:$45.79万
-
财政年份:1990
-
负责人:JAMES E MULLER
-
依托单位:
DETERMINANTS OF THE ONSET OF MYOCARDIAL INFARCTION
-
批准号:3358466
-
项目类别:
-
资助金额:$4.09万
-
财政年份:1990
-
负责人:JAMES E MULLER
-
依托单位:
TRIGGERS OF VENTRICULAR ARRHYTHMIAS (TOVA) STUDY
-
批准号:6182326
-
项目类别:
-
资助金额:$51.36万
-
财政年份:1990
-
负责人:JAMES E MULLER
-
依托单位:
TRIGGERS OF VENTRICULAR ARRHYTHMIAS (TOVA) STUDY
-
批准号:6389071
-
项目类别:
-
资助金额:$52.08万
-
财政年份:1990
-
负责人:JAMES E MULLER
-
依托单位:
MODIFIERS OF MYOCARDIAL INFARCTION ONSET
-
批准号:2219855
-
项目类别:
-
资助金额:$48.3万
-
财政年份:1990
-
负责人:JAMES E MULLER
-
依托单位:
TRIGGERS OF VENTRICULAR ARRHYTHMIAS (TOVA) STUDY
-
批准号:2849665
-
项目类别:
-
资助金额:$54.27万
-
财政年份:1990
-
负责人:JAMES E MULLER
-
依托单位:
DETERMINANTS OF THE ONSET OF MYOCARDIAL INFARCTION
-
批准号:3358469
-
项目类别:
-
资助金额:$47.41万
-
财政年份:1990
-
负责人:JAMES E MULLER
-
依托单位:
DETERMINANTS OF THE ONSET OF MYOCARDIAL INFARCTION
-
批准号:3358464
-
项目类别:
-
资助金额:$38.55万
-
财政年份:1989
-
负责人:JAMES E MULLER
-
依托单位:
CIRCADIAN VARIATION IN COAGULABILITY AND ITS MODIFICATION
-
批准号:3950823
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES E MULLER
-
依托单位:
EFFECT OF NADOLOL ON THE CIRCADIAN VARIABILITY OF PLATELET AGGREGATION
-
批准号:3907514
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES E MULLER
-
依托单位:
EFFECT OF CAPTOPRIL ON THE MORNING INCREASE OF PLATELET AGGREGABILITY
-
批准号:3907515
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES E MULLER
-
依托单位:
EFFECT OF PN200-110 ON THE MORNING INCREASE OF COAGULABILITY
-
批准号:3888093
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES E MULLER
-
依托单位:
COMPARISON OF BETAXOLOL & ATENOLOL ON RESPONSE TO MENTAL & PHYS. STRESS
-
批准号:3866974
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES E MULLER
-
依托单位:
RAPIDITY & DURATION OF SUPPRESSION OF PLATELET AGGREGABILITY BY ECOTRIN
-
批准号:3852375
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES E MULLER
-
依托单位:
BETAXOLOL & ATENOLOL COMPARISON OF RESPONSE TO MENTAL/PHYSICAL STRESS
-
批准号:3852358
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES E MULLER
-
依托单位:
BETAXOLOL VERSUS ATENOLOL--EFFECTS ON RESPONSE TO MENTAL AND PHYSICAL STRESS
-
批准号:3788770
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES E MULLER
-
依托单位:
POSSIBLE CIRCADIAN VARIATION IN COAGULABILITY
-
批准号:3928359
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:JAMES E MULLER
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Aspirin调控AKT/Foxo3a/BIM通路延缓吡咯替尼耐药作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:田武国
-
依托单位:
Aspirin与自噬通路及核转录因子FoxG1在听觉系统退行性变中的协同调控机制研究
-
批准号:81800915
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:贺祖宏
-
依托单位:
Aspirin联合牙周膜干细胞再生全脱位牙牙周组织机制研究
-
批准号:81760190
-
项目类别:地区科学基金项目
-
资助金额:32.0万元
-
批准年份:2017
-
负责人:王璇
-
依托单位:
可注射温敏型水凝胶缓释Aspirin碳点和EPO促牙周组织再生的研究
-
批准号:81600879
-
项目类别:青年科学基金项目
-
资助金额:17.0万元
-
批准年份:2016
-
负责人:徐晓薇
-
依托单位:
Aspirin协同IFN-α抑制肝癌转移复发的作用及机制研究
-
批准号:30972889
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2009
-
负责人:智绪亭
-
依托单位:
胃癌microRNA特异表达与靶基因调控及Aspirin的作用
-
批准号:30873099
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2008
-
负责人:王雪融
-
依托单位: